These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15742395)

  • 1. High-density lipoprotein as a potential carrier for delivery of a lipophilic antitumoral drug into hepatoma cells.
    Lou B; Liao XL; Wu MP; Cheng PF; Yin CY; Fei Z
    World J Gastroenterol; 2005 Feb; 11(7):954-9. PubMed ID: 15742395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of hydrophilic drug doxorubicin hydrochloride-targeted liver using apoAI as carrier.
    Yuan Y; Wang W; Wang B; Zhu H; Zhang B; Feng M
    J Drug Target; 2013 May; 21(4):367-74. PubMed ID: 23600747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant lipoproteins reinforce cytotoxicity of doxorubicin to hepatocellular carcinoma.
    Wang B; Yuan Y; Han L; Ye L; Shi X; Feng M
    J Drug Target; 2014 Jan; 22(1):76-85. PubMed ID: 24093636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted delivery of garcinia glycosides by reconstituted high-density lipoprotein nano-complexes.
    Liu C; Zhou Z; Chen Y; Liu J; Wang Y; Liu H
    J Microencapsul; 2018 Mar; 35(2):115-120. PubMed ID: 29195484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effects and pharmacokinetics of aclacinomycin A carried by injectable emulsions composed of vitamin E, cholesterol, and PEG-lipid.
    Wang J; Maitani Y; Takayama K
    J Pharm Sci; 2002 Apr; 91(4):1128-34. PubMed ID: 11948551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant high density lipoprotein nanoparticles for target-specific delivery of siRNA.
    Rui M; Tang H; Li Y; Wei X; Xu Y
    Pharm Res; 2013 May; 30(5):1203-14. PubMed ID: 23242841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of lipoprotein-like lipid particles for drug targeting: neo-high density lipoproteins.
    Schouten D; van der Kooij M; Muller J; Pieters MN; Bijsterbosch MK; van Berkel TJ
    Mol Pharmacol; 1993 Aug; 44(2):486-92. PubMed ID: 8355672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of polyethylene glycol linker chain length of folate-linked microemulsions loading aclacinomycin A on targeting ability and antitumor effect in vitro and in vivo.
    Shiokawa T; Hattori Y; Kawano K; Ohguchi Y; Kawakami H; Toma K; Maitani Y
    Clin Cancer Res; 2005 Mar; 11(5):2018-25. PubMed ID: 15756028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Combined Effect of Recombinant High-Density Lipoprotein Carrier and the Encapsulated Lovastatin in RAW264.7 Macrophage Cells Based on the Median-Effect Principle.
    Jiang C; Zhao Y; Yang Y; He J; Zhang W; Liu J
    Mol Pharm; 2018 Mar; 15(3):1017-1027. PubMed ID: 29382194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of acceptor particle size on the efflux of cellular free cholesterol.
    Davidson WS; Rodrigueza WV; Lund-Katz S; Johnson WJ; Rothblat GH; Phillips MC
    J Biol Chem; 1995 Jul; 270(29):17106-113. PubMed ID: 7615505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synergistic lethal effect of combined treatment of arsenic trioxide and aclacinomycin on human acute myeloid leukemia cell line KG-1a].
    Ye YB; Xu XJ; Chen YH; Zhang MW; Qiu DF; Guo ZW; He HQ
    Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):256-262. PubMed ID: 28550664
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor targeting effects of a novel modified paclitaxel-loaded discoidal mimic high density lipoproteins.
    Wang J; Jia J; Liu J; He H; Zhang W; Li Z
    Drug Deliv; 2013 Nov; 20(8):356-63. PubMed ID: 24079327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant high density lipoprotein reconstituted with apolipoprotein AI cysteine mutants as delivery vehicles for 10-hydroxycamptothecin.
    Zhang X; Chen B
    Cancer Lett; 2010 Dec; 298(1):26-33. PubMed ID: 20579804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of reconstituted high-density lipoprotein (rHDL) as a drug delivery platform - a detailed survey of rHDL particles ranging from biophysical properties to clinical implications.
    Simonsen JB
    Nanomedicine; 2016 Oct; 12(7):2161-2179. PubMed ID: 27237620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanostructured lipid carriers constituted from high-density lipoprotein components for delivery of a lipophilic cardiovascular drug.
    Zhang WL; Gu X; Bai H; Yang RH; Dong CD; Liu JP
    Int J Pharm; 2010 May; 391(1-2):313-21. PubMed ID: 20214958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RGD-modified liposomes enhance efficiency of aclacinomycin A delivery: evaluation of their effect in lung cancer.
    Feng C; Li X; Dong C; Zhang X; Zhang X; Gao Y
    Drug Des Devel Ther; 2015; 9():4613-20. PubMed ID: 26316700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and atherosclerotic lesions targeting effects of tanshinone IIA discoidal and spherical biomimetic high density lipoproteins.
    Zhang W; He H; Liu J; Wang J; Zhang S; Zhang S; Wu Z
    Biomaterials; 2013 Jan; 34(1):306-19. PubMed ID: 23069716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E3-mediated cellular uptake of reconstituted high-density lipoprotein bearing core 3, 10, or 17 nm hydrophobic gold nanoparticles.
    Chuang ST; Shon YS; Narayanaswami V
    Int J Nanomedicine; 2017; 12():8495-8510. PubMed ID: 29225464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tanshinone IIA-loaded reconstituted high density lipoproteins: Atherosclerotic plaque targeting mechanism in a foam cell model and pharmacokinetics in rabbits.
    Zhang W; Li J; Liu J; Wu Z; Xu Y; Wang J
    Pharmazie; 2012 Apr; 67(4):324-30. PubMed ID: 22570939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.